TKTae-Bum Kim

Tae-Bum Kim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tae-Bum Kim has a total of 82 co-authors. Here are the top co-authors by number of shared publications:

  • Hee-Bom Moon

    Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

    11 shared publications
  • You Sook Cho

    Department of Allergy and Clinical Immunology, Asan Medical Center University of Ulsan College of Medicine Seoul Republic of Korea

    11 shared publications
  • Yun-Jeong Bae

    Division of Allergy and Clinical Immunology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138-736, Korea

    7 shared publications
  • Hyouk-Soo Kwon

    Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

    6 shared publications
  • Sujeong Kim

    Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

    6 shared publications
  • So Young Park

    Division of Allergy and Clinical Immunology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138-736, Korea

    5 shared publications

Latest Publications

  • Open Access

    Heart transplantation in a patient with eosinophilic granulomatosis with polyangiitis known as Churg-Strauss syndrome

    by Taeeun Kim, Hyo Jung Kim, Bomi Shin, So Young Park, Hyouk-Soo Kwon, Hee-Bom Moon, You Sook Cho, Tae-Bum Kim

    Park S, et al. Allergy Asthma Respir Dis. 2015 Mar;3(2):159-163. http://dx.doi.org/10.4168/aard.2015.3.2.159


  • Open Access

    Risk Factors for Asthma-Related Healthcare Use: Longitudinal Analysis Using the NHI Claims Database in a Korean Asthma Cohort

    by Taehoon Lee, Jinhee Kim, Sujeong Kim, Kyoungjoo Kim, Yunjin Park, Yuri Kim, Yoon Su Lee, Hyouk-Soo Kwon, Sae-Hoon Kim, Yoon-Seok Chang, et al.

    Though insurance claims data are useful for researching asthma, they have important limitations, such as a diagnostic inaccuracy and a lack of clinical information. To overcome these drawbacks, we used the novel method by merging the clinical data from our asthma cohort with the National Health Insurance (NHI) claims data. Longitudinal analysis of asthma-related healthcare use from the NHI claims database, merged with data of 736 patients registered in a Korean asthma cohort, was conducted for three consecutive years from registration of the cohort. Asthma-related asthma healthcare referred to outpatient and emergency department visits, hospitalizations, and the use of systemic corticosteroids. Univariate and multivariate logistic regression analysis was used to evaluate risk factors for asthma-related healthcare. Over three years after enrollment, many patients changed from tertiary to primary/secondary hospitals with a lack of maintenance of inhaled corticosteroid-based controllers. An independent risk factor for emergency visits was a previous history of asthma exacerbation. In hospitalizations, old age and Asthma Control Test (ACT) score variability were independent risk factors. An independent risk factor for per person cumulative duration of systemic corticosteroids was the FEV1 (Forced expiratory volume in one second)%. The use of systemic corticosteroids was independently associated with being female, the FEV1%, and ACT score variability. We found that old age, being female, long-standing asthma, a low FEV1%, asthma brittleness, asthma drug compliance, and a history of asthma exacerbation were independent risk factors for increased asthma-related healthcare use in Korea.


  • Open Access

    Eosinophilic organ infiltration without eosinophilia or direct parasite infection

    by Il Young Jang, Young-Joo Yang, Hyung Jin Cho, Yunsik Choi, Eun-Hye Shin, Dong-Uk Kang, Tae-Bum Kim

    Jang IY, et al. Korean J Intern Med. 2014 Jan;29(1):126-129. http://dx.doi.org/10.3904/kjim.2014.29.1.126


  • Open Access

    Rapid onset of Stevens-Johnson syndrome and toxic epidermal necrolysis after ingestion of acetaminophen

    by Eun-Jin Kim, Hyun Lim, So Young Park, Sujeong Kim, Sun-Young Yoon, Yun-Jeong Bae, Hyouk-Soo Kwon, You Sook Cho, Hee-Bom Moon, Tae-Bum Kim

    Kim EJ, et al. Asia Pac Allergy. 2014 Jan;4(1):68-72. https://doi.org/10.5415/apallergy.2014.4.1.68


  • Open Access

    Clinical Significance of Asthma Clusters by Longitudinal Analysis in Korean Asthma Cohort

    by So Young Park, Seunghee Baek, Sujeong Kim, Sun-Young Yoon, Hyouk-Soo Kwon, Yoon-Seok Chang, You Sook Cho, An-Soo Jang, Jung Won Park, Dong-Ho Nahm, et al.

    We have previously identified four distinct groups of asthma patients in Korean cohorts using cluster analysis: (A) smoking asthma, (B) severe obstructive asthma, (C) early-onset atopic asthma, and (D) late-onset mild asthma. A longitudinal analysis of each cluster in a Korean adult asthma cohort was performed to investigate the clinical significance of asthma clusters over 12 months. Cluster A showed relatively high asthma control test (ACT) scores but relatively low FEV1 scores, despite a high percentage of systemic corticosteroid use. Cluster B had the lowest mean FEV1, ACT, and the quality of life questionnaire for adult Korean asthmatics (QLQAKA) scores throughout the year, even though the percentage of systemic corticosteroid use was the highest among the four clusters. Cluster C was ranked second in terms of FEV1, with the second lowest percentage of systemic corticosteroid use, and showed a marked improvement in subjective symptoms over time. Cluster D consistently showed the highest FEV1, the lowest systemic corticosteroid use, and had high ACT and QLQAKA scores. Our asthma clusters had clinical significance with consistency among clusters over 12 months. These distinctive phenotypes may be useful in classifying asthma in real practice.


  • Healthcare use and prescription patterns associated with adult asthma in Korea: analysis of the NHI claims database

    by S. Kim, J. Kim, K. Kim, Y. Kim, Y. Park, S. Baek, S. Y. Park, S.-Y. Yoon, H.-S. Kwon, Y. S. Cho, et al.

    Background National Health Insurance (NHI) claim records could provide valuable data for epidemiological studies of asthma in Korea. The aim of this study is to estimate the prevalence of adult asthma and to investigate asthma‐related healthcare use and prescription patterns in Korea over 5 years. Methods National Health Insurance claim records from January 1, 2006 to December 31, 2010 were analyzed in a retrospective, population‐based study. Outcome measures included asthma prevalence, healthcare use, and prescription patterns over time, by type of hospital, and by medical specialty. Additionally, we assessed differences in healthcare use between newly diagnosed and previously diagnosed patients in 2009. Results Over 5 years, the prevalence of asthma among Korean adults increased from 4944 to 5707 cases per 100 000 population (from 3760 to 4445 in men and from 6108 to 6951 in women). Asthma‐related outpatient visits decreased from 4.82 ± 8.02 to 3.44 ± 5.50. Approximately 3% of all patients were hospitalized and 2.4% received asthma‐related emergency treatment each year. Pulmonary function tests were performed in 10–11% of patients an average of 1.3 times per year. Newly diagnosed patients experienced fewer asthma‐related hospitalizations (1.78% vs 4.35%) and emergency department visits (0.80% vs 2.11%) than the previously diagnosed group. Prescriptions of inhaled corticosteroids‐based inhalers were maintained with about 20% of average of all types of hospitals. Conclusions The prevalence of asthma in Korea has increased over a recent 5‐year period, and asthma is still suboptimally controlled. Public health strategies are needed to improve the management of asthma in adults.


  • Open Access

    Influence of Initial Treatment Modality on Long-Term Control of Chronic Idiopathic Urticaria

    by Sujeong Kim, Seunghee Baek, Bomi Shin, Sun-Young Yoon, So Young Park, Taehoon Lee, Yoon Su Lee, Yun-Jeong Bae, Hyouk Soo Kwon, You Sook Cho, et al.

    Chronic idiopathic urticaria (CIU) is a common cutaneous disorder but the influence of initial treatment modality on long-term control is not known. The aim of this study was to evaluate clinical features, and the influence of initial treatment modality on long-term control. 641 CIU patients were enrolled from the allergy clinic in a tertiary referral hospital. Disease duration, aggravating factors and treatment modality at each visit were evaluated. Times required to reach a controlled state were analyzed according to initial treatment modality, using Kaplan-Meier survival curves, the Cox proportional-hazards model, and propensity scores. Female to male ratio was 1.7: 1; mean age at onset was 40.5 years. The most common aggravating factors were food (33.5%), stress (31.5%) and fatigue (21.6%). Most patients (82.2%) used H1-antihistamines alone as initial treatment while 17% used a combination treatment with oral corticosteroids. There was no significant difference in the time taken to reach a controlled state between patients treated with single vs multiple H1-antihistamines or between those who received H1-antihistamine monotherapy vs. a combination therapy with oral corticosteroids. The time required to control CIU is not reduced by use of multiple H1-antihistamines or oral corticosteroids in the initial treatment.


  • Open Access

    The Effectiveness of Automatic Recommending System for Premedication in Reducing Recurrent Radiocontrast Media Hypersensitivity Reactions

    by Yun-Jeong Bae, Ye Won Hwang, Sun-Young Yoon, Sujeong Kim, Taehoon Lee, Yoon Su Lee, Hyouk-Soo Kwon, You Sook Cho, Myung Jin Shin, Hee-Bom Moon, et al.

    Non-ionic radiocontrast media (RCM) is rarely associated with hypersensitivity reactions. Premedication of patients who reacted previously to RCM with systemic corticosteroids and/or antihistamines can help reduce recurrent hypersensitivity reactions. However, premedication is still not prescribed in many cases for various reasons. This study aimed to determine the effectiveness of our novel RCM hypersensitivity surveillance and automatic recommending system for premedication. Hospitalized patients with a history of RCM hypersensitivity were identified in an electronic medical record system that included a mandatory reporting system for past adverse drug reactions. In 2009, a novel automatic prescription system was added that classified index RCM reactions by severity and dispensed appropriate corticosteroid and/or antihistamine pretreatment prior to new RCM exposures. The data from 12 months under the previous system and 12 months under the current system were compared. The two systems had similar overall premedication rates (91% and 95%) but the current system was associated with a significantly higher corticosteroid premedication rate (65% vs. 14%), which significantly reduced the breakthrough reaction rate (6.7% vs. 15.2%). The current system was also associated with increased corticosteroid and antihistamine premedication of patients with a mild index reaction (61% vs. 7%) and a reduction in their breakthrough reaction rate (6% vs. 15%). Premedication with corticosteroid and/or antihistamine, which was increased by our novel automatic prescription system, significantly reduced breakthrough reactions in patients with a history of RCM hypersensitivity.


  • Validation of the cephalosporin intradermal skin test for predicting immediate hypersensitivity: a prospective study with drug challenge

    by S.‐Y. Yoon, S. Y. Park, S. Kim, T. Lee, Y. S. Lee, H.‐S. Kwon, Y. S. Cho, H.‐B. Moon, T.‐B. Kim

    Background: Cephalosporin is a major offending agent in terms of drug hypersensitivity along with penicillin. Cephalosporin intradermal skin tests (IDTs) have been widely used; however, their validity for predicting immediate hypersensitivity has not been studied. This study aimed to determine the predictive value of cephalosporin intradermal skin testing before administration of the drug.Methods: We prospectively conducted IDTs with four cephalosporins, one each of selected first‐, second‐, third‐, or fourth‐generation cephalosporins: ceftezol; cefotetan or cefamandole; ceftriaxone or cefotaxime; and flomoxef, respectively, as well as with penicillin G. After the skin test, whatever the result, one of the tested cephalosporins was administered intravenously and the patient was carefully observed.Results: We recruited 1421 patients who required preoperative cephalosporins. Seventy‐four patients (74/1421, 5.2%) were positive to at least one cephalosporin. However, none of responders had immediate hypersensitivity reactions after a challenge dose of the same or different cephalosporin, which were positive in the skin test. Four patients who suffered generalized urticaria and itching after challenge gave negative skin tests for the corresponding drug. The IDT for cephalosporin had a sensitivity of 0%, a specificity of 97.5%, a negative predictive value of 99.7%, and a positive predictive value (PPV) of 0%, when challenged with the same drugs that were positive in the skin test.Conclusion: Routine skin testing with a cephalosporin before its administration is not useful for predicting immediate hypersensitivity because of the extremely low sensitivity and PPV of the skin test (CRIS registration no. KCT0000455).


  • Open Access

    A Case of Idiopathic Anaphylaxis Followed by Acute Liver Injury

    by Sujeong Kim, Sun-Young Yoon, So Young Park, Hyouk-Soo Kwon, You Sook Cho, Hee-Bom Moon, Tae-Bum Kim

    Kim S, et al. Allergy Asthma Immunol Res. 2013 Jul;5(4):245-247. https://doi.org/10.4168/aair.2013.5.4.245